Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Open Access | Times Cited: 295

Showing 51-75 of 295 citing articles:

Targeting PPARs for therapy of atherosclerosis: A review
Miao Miao, Xue Wang, Tian Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125008-125008
Closed Access | Times Cited: 22
Ameliorative effects of mangiferin derivative TPX on insulin resistance via PI3K/AKT and AMPK signaling pathways in human HepG2 and HL-7702 hepatocytes
Xiangcheng Fan, Guangyang Jiao, Tao Pang, et al.
Phytomedicine (2023) Vol. 114, pp. 154740-154740
Closed Access | Times Cited: 21
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Chenxi Qin, Lina‐Marcela Diaz‐Gallo, Bowen Tang, et al.
European Journal of Epidemiology (2023) Vol. 38, Iss. 7, pp. 809-819
Open Access | Times Cited: 20
Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs
Yutong Zhou, Wendong Suo, Xinai Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115669-115669
Open Access | Times Cited: 19
Antidiabetic Plants for the Treatment of Type 2 Diabetes Mellitus and Associated Bacterial Infections
Mario Adrián Tienda-Vázquez, Elda M. Melchor-Martínez, Joel Horacio Elizondo‐Luévano, et al.
Processes (2023) Vol. 11, Iss. 5, pp. 1299-1299
Open Access | Times Cited: 17
Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database
Matthew Anson, Alex E. Henney, Sizheng Steven Zhao, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2606-2623
Closed Access | Times Cited: 8
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models
Emma Puighermanal, Marta Luna‐Sánchez, Alejandro Gella, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials
Cheng Han Ng, Snow Yunni Lin, Yip Han Chin, et al.
Endocrine Practice (2021) Vol. 28, Iss. 2, pp. 223-230
Closed Access | Times Cited: 40
The Effects of Major Mushroom Bioactive Compounds on Mechanisms That Control Blood Glucose Level
Jelena Arambašić Јovanović, Mirjana Mihailović, Aleksandra Uskoković, et al.
Journal of Fungi (2021) Vol. 7, Iss. 1, pp. 58-58
Open Access | Times Cited: 38
Potential Mechanisms of the Improvement of Glucose Homeostasis in Type 2 Diabetes by Pomegranate Juice
Carlos Olvera‐Sandoval, Héctor Enrique Fabela‐Illescas, Eduardo Fernández‐Martínez, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 553-553
Open Access | Times Cited: 26
Adsorption Mechanism of Eco-Friendly Corrosion Inhibitors for Exceptional Corrosion Protection of Carbon Steel: Electrochemical and First-Principles DFT Evaluations
Abdelkarim Chaouiki, Maryam Chafiq, Young Gun Ko, et al.
Metals (2022) Vol. 12, Iss. 10, pp. 1598-1598
Open Access | Times Cited: 24
Targeting Adiponectin in Breast Cancer
Rawan Nehme, Mona Diab‐Assaf, Caroline Decombat, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2958-2958
Open Access | Times Cited: 24
Seaweed Derived Lipids Are a Potential Anti-Inflammatory Agent: A Review
Agnieszka Jaworowska, Aliza Murtaza
International Journal of Environmental Research and Public Health (2022) Vol. 20, Iss. 1, pp. 730-730
Open Access | Times Cited: 24
Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases
Vinesh Sharma, Vikram Patial
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas
Henrique Souza-Tavares, Carolline Santos Miranda, Isabela Macedo Lopes Vasques‐Monteiro, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4136-4155
Open Access | Times Cited: 15
Old age as a risk factor for liver diseases: Modern therapeutic approaches
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva
Experimental Gerontology (2023) Vol. 184, pp. 112334-112334
Open Access | Times Cited: 14
Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: A network meta-analysis
Hayeon Kim, Cheol Ung Choi, Kiyon Rhew, et al.
Atherosclerosis (2024) Vol. 391, pp. 117490-117490
Closed Access | Times Cited: 5
Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study
Alomgir Hossain, Md. Ekhtiar Rahman, Md Omar Faruqe, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 483-483
Open Access | Times Cited: 5
Liposomal quercetin: A promising strategy to combat hepatic insulin resistance and inflammation in type 2 diabetes mellitus
Sónia Rocha, M. Luísa Corvo, Marisa Freitas, et al.
International Journal of Pharmaceutics (2024) Vol. 661, pp. 124441-124441
Open Access | Times Cited: 5
The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?
Abhipree Sharma, Michael Mah, Rebecca H. Ritchie, et al.
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108008-108008
Closed Access | Times Cited: 31
Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review
Yasaman Sharifi, Moloud Payab, Erfan Mohammadi-Vajari, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 2, pp. 1743-1765
Open Access | Times Cited: 30
AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals
Min‐Yu Chung, Hyo‐Kyoung Choi, Jin‐Taek Hwang
Nutrients (2021) Vol. 13, Iss. 11, pp. 4050-4050
Open Access | Times Cited: 30
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
Carmelo Quarta, Kerstin Stemmer, Aaron Novikoff, et al.
Nature Metabolism (2022) Vol. 4, Iss. 8, pp. 1071-1083
Open Access | Times Cited: 22
Synthesis, Anticancer Activity and Molecular Docking Studies of Hybrid Molecules Containing Indole‐Thiazolidinedione‐Triazole Moieties
Nagaraju Perike, Praveen Kumar Edigi, Nirmala Gurrapu, et al.
ChemistrySelect (2022) Vol. 7, Iss. 47
Closed Access | Times Cited: 21
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review
Kumari Kajal, Gurpreet Singh, Tathagata Pradhan, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 20

Scroll to top